Nebius Is The Preferred Pick Over CoreWeave Post-Q3 Earnings

Nebius Group N.V. (NBIS) is favored over CoreWeave (CRWV) following Q3 earnings, with NBIS reporting 355% year-over-year revenue growth, margin expansion, and a cleaner balance sheet, leading to significantly raised long-term guidance and a 'Buy' rating. Conversely, CRWV, despite strong Q3 revenue and EPS beats, faces margin compression, supply chain delays, and a heavy debt burden, resulting in guidance and CAPEX cuts and a 'Hold' rating. This positions NBIS as the stronger investment due to its superior financial health and growth trajectory, with a projected 75% upside.

Analysis

Nebius Group N.V. (NBIS) is highlighted as the preferred investment over CoreWeave (CRWV) following Q3 earnings, driven by superior financial health and growth metrics. NBIS reported robust 355% year-over-year revenue growth in Q3, alongside margin expansion and a cleaner balance sheet, leading management to significantly raise long-term ARR and capacity guidance. This trajectory indicates a clearer path to profitability and strong operational execution.

Conversely, CoreWeave (CRWV), despite achieving strong Q3 revenue and EPS beats, faces significant operational headwinds. The company is grappling with margin compression, persistent supply chain delays, and a substantial debt burden, which have collectively prompted cuts to its guidance and capital expenditure plans. While CRWV possesses a large backlog, these challenges temper its near-term outlook.

The analyst's valuation suggests a potential 75% upside for NBIS stock over the next two years, assigning it a "Buy" rating, while CRWV receives a "Hold". This divergence reflects NBIS's stronger fundamental positioning, characterized by superior financial health and a more favorable growth trajectory, making it the clear winner in this competitive sector.

Key Decisions for Investors

• Consider Nebius Group N.V. (NBIS) for long positions, supported by its 355% Q3 revenue growth, margin expansion, and raised long-term guidance, which underpin a projected 75% upside.
• Maintain a "Hold" position on CoreWeave (CRWV), as its Q3 revenue and EPS beats are overshadowed by margin compression, supply chain delays, and a heavy debt burden leading to guidance cuts.
• Closely monitor the execution of capacity expansion and supply chain improvements for both companies, as these are critical drivers for future performance in this high-demand sector.